Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention

PHASE3RecruitingINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

July 31, 2026

Conditions
HIV InfectionsAdherence, Medication
Interventions
BEHAVIORAL

A-TEAM

Participants randomized to the intervention arm will receive the proposed intervention, which involves an electronic adherence device called Wisepill and triaged text alerts to the user, the social support, and the case manager for same day, two day, and seven day device non-openings.

Trial Locations (1)

60612

RECRUITING

University of Illinois Chicago, Chicago

All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

lead

University of Illinois at Chicago

OTHER